Magnus Medical is a privately held medical device company driven to transform lives by restoring mental health. Magnus' first FDA-cleared product is the SAINT™ Neuromodulation System, which received FDA Breakthrough Device Designation for its novel, rapid-acting therapy for treatment-resistant depression. The SAINT Neuromodulation System yields a new form of individualized neurostimulation for adults who have failed to achieve satisfactory improvement from prior antidepressant medications.